“[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-Per-Responder Analysis]”. Farmeconomia. Health Economics and Therapeutic Pathways 26, no. 1 (May 8, 2025). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1571.